- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.01. | MEDIROM Healthcare Technologies Inc.: World, Co-founded by Sam Altman and Alex Blania, Accelerates Expansion in Japan via MEDIROM Collaboration Re.Ra.Ku's "Orb" Authentication Surpasses 20,000 Cumulative Verifications, Doubling in Approximately ... | 2 | GlobeNewswire (USA) | ||
| MEDIROM HEALTHCARE TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| 08.01. | Medirom Healthcare Technologies Inc. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 29.12.25 | MEDIROM Healthcare Technologies Inc.: MEDIROM Partners with World on Technology Envisioned by Sam Altman and Alex Blania: Deploying "Proof of Human" Infrastructure throughout Japan | 2 | GlobeNewswire (USA) | ||
| 29.12.25 | MEDIROM Healthcare partners with World Foundation to deploy World ID technologies across Japan | 3 | Seeking Alpha | ||
| 27.12.25 | MEDIROM Healthcare Technologies Inc.: MEDIROM Partners with World | 1 | GlobeNewswire (USA) | ||
| 22.12.25 | Medirom Healthcare Technologies Inc. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 15.12.25 | Medirom Healthcare Technologies Inc. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 04.12.25 | MEDIROM: Vertriebspartnerschaft mit TD SYNNEX soll Smart-Tracker-Absatz in Japan beschleunigen | 1 | Investing.com Deutsch | ||
| 04.12.25 | MEDIROM subsidiary partners with TD SYNNEX to expand smart tracker sales | 1 | Investing.com | ||
| 04.12.25 | MEDIROM Healthcare Technologies Inc.: MEDIROM Mother Labs Partners with TD SYNNEX to Accelerate National Adoption of "MOTHER Bracelet" and "REMONY" | 205 | GlobeNewswire (Europe) | TOKYO, Dec. 04, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) ("MEDIROM") today announced that its subsidiary, MEDIROM MOTHER Labs Inc. ("MOTHER Labs"), which develops... ► Artikel lesen | |
| 03.12.25 | Medirom Healthcare Technologies Inc. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 30.10.25 | MEDIROM Healthcare Technologies Inc.: MEDIROM MOTHER Labs Inc. Receives Capital Investment from Internal Investors | 1 | GlobeNewswire (USA) | ||
| 29.10.25 | MEDIROM Healthcare Technologies Inc.: MEDIROM to Launch New Treasury Strategy Utilizing Cryptocurrency | 734 | GlobeNewswire (Europe) | TOKYO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc., (Headquarters: Minato-ku, Tokyo; President and CEO: Kouji Eguchi; listed on the Nasdaq Stock Market under the ticker... ► Artikel lesen | |
| 29.10.25 | Medirom Healthcare Technologies Inc. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 28.10.25 | MEDIROM Healthcare Technologies Inc.: More than 10,000 people receive verified World IDs at MEDIROM locations | 1 | GlobeNewswire (USA) | ||
| 21.10.25 | Medirom Healthcare Technologies Inc. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 09.10.25 | Privatplatzierung bei Tochtergesellschaft beflügelt Medirom-Aktie | 5 | Investing.com Deutsch | ||
| 09.10.25 | Medirom stock soars after subsidiary approves private placement | 2 | Investing.com | ||
| 09.10.25 | Medirom Healthcare Technologies Inc. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 26.09.25 | Medirom stock soars after joining Sam Altman's World ID protocol | 5 | Investing.com |
1 2 Weiter >>
34 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PAVMED | 11,970 | 0,00 % | PAVmed-subsidiary Lucid Diagnostics spikes on Veterans Affairs contract | ||
| SIEMENS HEALTHINEERS | 43,630 | -2,00 % | ANALYSE-FLASH: UBS hebt Ziel für Siemens Healthineers auf 51 Euro - 'Neutral' | ZÜRICH (dpa-AFX Broker) - Die Schweizer Großbank UBS hat das Kursziel für Siemens Healthineers von 50 auf 51 Euro angehoben, aber die Einstufung auf "Neutral" belassen. Die Aktien der Bayern seien... ► Artikel lesen | |
| FRESENIUS | 47,640 | +1,10 % | Fresenius lizenziert Zellselektionstechnologie von TQ Therapeutics ein | DJ Fresenius lizenziert Zellselektionstechnologie von TQ Therapeutics ein
DOW JONES--Fresenius hat für seine Tochter Kabi eine exklusive Lizenz zur Entwicklung, Herstellung sowie zum Vertrieb von... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 36,630 | +1,81 % | AKTIE IM FOKUS: FMC schließen sich Davita-Schwäche an - Grippesaison in USA | FRANKFURT (dpa-AFX Broker) - Die Aktien von FMC sind am Mittwoch unter 37 Euro und damit auf das tiefste Niveau seit Herbst 2024 gefallen. Dabei verloren die Papiere des Dialysekonzerns 6 Prozent.... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 35,200 | -0,73 % | Carl Zeiss Meditec-Aktie -6%: Darum geht der Crash weiter | Die Aktien von Carl Zeiss Meditec sind am Dienstag erneut massiv unter Druck geraten. Darum geht der Crash bei den Papieren des MDAX-Konzerns jetzt weiter. Goldman Sachs pessimistisch Goldman-Analyst... ► Artikel lesen | |
| HEARTFLOW | 33,550 | -1,87 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| ANTERIS TECHNOLOGIES GLOBAL | 6,060 | 0,00 % | Anteris Technologies Global Corp. Announces Proposed $200 Million Public Offering of Common Stock and Strategic Investment from Medtronic | MINNEAPOLIS and BRISBANE, Australia, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ: AVR, ASX: AVR), a global structural heart company committed... ► Artikel lesen | |
| GENEDX | 100,04 | +0,36 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PROGYNY | 25,450 | +0,28 % | Forecasting The Future: 6 Analyst Projections For Progyny | ||
| PRIVIA HEALTH GROUP | 23,600 | +1,68 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| RXSIGHT | 9,950 | 0,00 % | Expert Outlook: RxSight Through The Eyes Of 5 Analysts | ||
| BRIGHTSPRING HEALTH SERVICES | 39,210 | +1,24 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 23,300 | +2,46 % | Alignment Healthcare Named to the 2026 Fortune World's Most Admired Companies List for First Time | ||
| PROCEPT BIOROBOTICS | 30,940 | +2,08 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| UNITEDHEALTH | 297,40 | +2,98 % | UNITEDHEALTH GROUP INC zeigt strukturelle Stärke |
Das Unternehmen MEDIROM HEALTHCARE TECHNOLOGIES INC ADR kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 1,685 Euro und damit -0,88 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MEDIROM HEALTHCARE TECHNOLOGIES INC ADR finden Sie auf Wallstreet Online.